BLRX - BioLineRx Ltd.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 590.64M
Enterprise Value 340.19M
Trailing P/E N/A
Forward P/E 1-4.00
PEG Ratio (5 yr expected) 10.12
Price/Sales (ttm)N/A
Price/Book (mrq)1.67
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-1.62

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Dec 31, 2017

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-31.58%
Return on Equity (ttm)-55.40%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -24.8M
Net Income Avi to Common (ttm)-24.35M
Diluted EPS (ttm)-0.2710
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)49.48M
Total Cash Per Share (mrq)0.47
Total Debt (mrq)250k
Total Debt/Equity (mrq)0.47
Current Ratio (mrq)7.49
Book Value Per Share (mrq)0.50

Cash Flow Statement

Operating Cash Flow (ttm)-20.55M
Levered Free Cash Flow (ttm)-15.36M

Trading Information

Stock Price History

Beta 0.02
52-Week Change 30.92%
S&P500 52-Week Change 312.47%
52 Week High 31.3400
52 Week Low 30.8000
50-Day Moving Average 30.9156
200-Day Moving Average 31.0355

Share Statistics

Avg Vol (3 month) 3305.88k
Avg Vol (10 day) 3137.78k
Shares Outstanding 5104.12M
Float 64.02M
% Held by Insiders 14.70%
% Held by Institutions 139.50%
Shares Short 3298.86k
Short Ratio 31.01
Short % of Float 30.00%
Shares Short (prior month) 3345.44k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A